What's new

Human medicines European public assessment report (EPAR): Koselugo, selumetinib, Date of authorisation: 17/06/2021, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR): Koselugo, selumetinib, Date of authorisation: 17/06/2021, Revision: 6, Status: Authorised

Mar 14, 2025 - 15:07
 0
Human medicines European public assessment report (EPAR): Koselugo, selumetinib, Date of authorisation: 17/06/2021, Revision: 6, Status: Authorised
Human medicines European public assessment report (EPAR): Koselugo, selumetinib, Date of authorisation: 17/06/2021, Revision: 6, Status: Authorised
Read More

Tags:

Previous Article

Veterinary medicines European public assessment report (EPAR): Mhyosphere PCV ID...

Next Article

Spontaneous Passivation of Selective Zn (101) Plating via Dangling Bond Saturati...

Related Posts

Orphan designation: Adeno-associated viral vector serotype 9 containing the human N-acetylglucosaminidase-alpha gene Treatment of mucopolysaccharidosis type IIIB (Sanfilippo B syndrome), 24/01/2013 Withdrawn

Orphan designation: Adeno-associated viral vector serot...

Feb 20, 2025  0

Human medicines European public assessment report (EPAR): Wyost, denosumab, Date of authorisation: 17/05/2024, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 9, 2025  0

Orphan designation: volixibat potassium Treatment of primary biliary cholangitis, 16/01/2025 Positive

Orphan designation: volixibat potassium Treatment of pr...

Feb 20, 2025  0